Combinatorial Cancer Immunotherapies
Author:
Publisher
Elsevier
Reference170 articles.
1. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes;Agata;International Immunology,1996
2. OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand;al-Shamkhani;European Journal of Immunology,1996
3. Talimogene laherparepvec improves durable response rate in patients with advanced melanoma;Andtbacka;Journal of Clinical Oncology,2015
4. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma;Ansell;The New England Journal of Medicine,2015
5. Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032;Antonia;American Society of Clinical Oncology Meeting Abstracts,2015
Cited by 95 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Atypical artificial cells: Novel biomimetic materials for combating cancer;Interdisciplinary Materials;2024-07-17
2. Computational identification and experimental verification of a novel signature based on SARS-CoV-2–related genes for predicting prognosis, immune microenvironment and therapeutic strategies in lung adenocarcinoma patients;Frontiers in Immunology;2024-03-26
3. Combinatorial immune checkpoint blockade increases myocardial expression of NLRP-3 and secretion of H-FABP, NT-Pro-BNP, interleukin-1β and interleukin-6: biochemical implications in cardio-immuno-oncology;Frontiers in Cardiovascular Medicine;2024-01-23
4. The Defined TLR3 Agonist, Nexavant, Exhibits Anti-Cancer Efficacy and Potentiates Anti-PD-1 Antibody Therapy by Enhancing Immune Cell Infiltration;Cancers;2023-12-08
5. Cancer Immunotherapy;Veterinary Clinics of North America: Small Animal Practice;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3